Algorithm specification interface for human immunodefiency virus type 1 genotypic interpretation [2]

Journal of Clinical Microbiology

Volumn 41, Issue 6, 2003, Pages 2792-2794

  Betts, Bradley J ^a   Shafer, Robert W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ALGORITHM; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS GENOME; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0038179411     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.6.2792-2794.2003     Document Type: Letter

References (8)

1. DeGruttola, V., L. Dix, R. D'Aquila, D. Holder, A. Phillips, M. Ait-Khaled, J. Baxter, P. Clevenbergh, S. Hammer, R. Harrigan, D. Katzenstein, R. Lanier, M. Miller, M. Para, S. Yerly, A. Zolopa, J. Murray, A. Patick, V. Miller, S. Castillo, L. Pedneault, and J. Mellors. 2000. The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir. Ther. 5:41-48.
2. Kijak, G. H., A. E. Rubio, S. E. Pampuro, C. Zala, P. Cahn, R. Galli, J. S. Montaner, and H. Salomon. 2003. Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms. HIV Med. 4:72-78.
3. Meynard, J. L., M. Vray, L. Morand-Joubert, E. Race, D. Descamps, G. Peytavin, S. Matheron, C. Lamotte, S. Guiramand, D. Costagliola, F. Brun-Vizinet, F. Clavel, and P.-M. Girard. 2002. Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial. AIDS 16:727-736.
4. Puchhammer-Stockl, E., C. Steininger, E. Geringer, and F. X. Heinz. 2002. Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains. HIV Med. 3:200-206.
5. Ravela, J., B. J. Betts, F. Brun-Vezinet, A. M. Vandamme, D. Descamps, K. Van Loethem, K. Smith, J. M. Shapiro, D. Winslow, C. Reid, and R. W. Shafer. 2003. HIV-1 protease and reverse transcriptase mutation patterns causing discordances between drug resistance interpretation algorithms. J. Acquir. Immun. Defic. Syndr. 33:8-14.
6. Rousseau, M. N., L. Vergne, B. Montes, M. Peeters, J. Reynes, E. Delaporte, and M. Segondy. 2001. Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 26:36-43.
7. Shafer, R. W., D. Stevenson, and B. Chan. 1999. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 27:348-352.
8. Van Laethem, K., A. De Luca, A. Antinori, A. Cingolani, C. F. Perno, and A.-M. Vandamme. 2002. A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients. Antivir. Ther. 7:123-129.